CIK 0001816736
- Large accelerated filer
Disc Medicine, Inc.
Sign in to watch- Ticker
- IRON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 851612845
- Phone
- +1 617-674-9274
- Business address
- 321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
- Former names
- Gemini Therapeutics, Inc. /DE, FS Development Corp.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Operating Officer sold 18,612 shares at an average $69.19 ($1,287,801)
- 4 Planned sale Chief Medical Officer sold 5,731 shares at an average $66.38 ($380,449)
- 4 Planned sale Chief Financial Officer sold 6,657 shares at an average $69.23 ($460,834)
- 4 Planned sale Chief Medical Officer sold 7,378 shares at an average $65.88 ($486,069)
- 4 Planned sale Chief Financial Officer sold 353 shares at $69.06 ($24,377)
- 4 Planned sale Chief Financial Officer sold 11,156 shares at an average $64.51 ($719,727)
- 4 Open-market sale Chief Legal Officer sold 2,853 shares at $62.86 ($179,340)
- 4 Open-market sale Chief Commercial Officer sold 5,531 shares at $62.86 ($347,679)
- 4 Open-market sale Chief Medical Officer sold 3,256 shares at $62.86 ($204,672)
- 4 Open-market sale Chief Operating Officer sold 3,231 shares at $62.86 ($203,101)
- 4 Open-market sale Chief Executive Officer sold 13,264 shares at $62.86 ($833,775)
- 4 Grant or award Chief Legal Officer acquired 17,000 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 17,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 17,000 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 17,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 19,000 shares (grant or award)
Page 2 of 15 · 283 filings